Beneficient
About Beneficient
Beneficient is a technology-enabled financial services holding company that (together with its subsidiaries) provides simple, rapid, and cost-effective liquidity solutions to participants in the alternative asset industry through its end-to-end online platform, AltAccess. BCG's products and services are designed to meet the unmet needs of mid-to-high net-worth individual investors, small-to-midsize institutional investors, family offices, and fund general partners. Its bespoke liquidity solutions for otherwise illiquid alternative asset investments are delivered through proprietary technology and a financing and trust structure. It has three reportable segments consisting of Ben Liquidity, Ben Custody and Customer ExAlt Trusts.
This profile is unclaimed. An authorized representative can claim it to add details and earn the Verified badge.
Financial summary
- Revenue FY2025
- -$7.9M
- Net income
- -$2.1B
- Total assets
- $354.9M
- Market cap
- $50.8M
- Operating margin
- 304.5%
- Net margin
- 10.1%
Source: SEC EDGAR · updated Jun 8, 2026
Revenue & profit trend
Financial statements
Income statement
- Revenue
- -$7.9M
- Operating expenses
- $16.2M
- Operating income
- -$24.2M
- Income tax
- $80.0K
- Net income
- -$803.0K
Balance sheet
- Total assets
- $354.9M
- Current assets
- $354.9M
- Total liabilities
- $299.3M
- Current liabilities
- $299.3M
- Shareholders’ equity
- -$34.9M
Cash flow
- Operating cash flow
- -$37.7M
- Investing cash flow
- $28.1M
- Financing cash flow
- $3.0M
- Net cash flow
- -$6.6M
Statements via Polygon.io (SEC filings)
15-minute delayed · data by Polygon.io
Past year
52-week range
- Market cap
- $50.8M
- Shares outstanding
- 15.0M
- Open
- —
- Day range
- –
- Prev close
- —
- Volume
- —
- IPO date
- Jun 8, 2023
Market data by Polygon.io · prices are 15-minute delayed
At a glance
- Reported a net loss of $2.1B in FY2025.
- Revenue grew 92% from FY2024 to FY2025.
- Trading 72% below its 52-week high.
Automatically generated from public filings and market data. Informational only — not investment advice or a recommendation to buy or sell any security.
No reviews yet. Be the first to review Beneficient.
Write a review
News about Beneficient
News & sentiment via Polygon.io
